331
Participants
Start Date
February 7, 2013
Primary Completion Date
November 27, 2013
Study Completion Date
December 19, 2013
Evolocumab
Administered by subcutaneous injection
Placebo
Administered by subcutaneous injection
Research Site, Midrand
Research Site, Camperdown
Research Site, Johannesburg
Research Site, Reinach
Research Site, Perth
Research Site, Parow
Research Site, Observatory
Research Site, Christchurch
Research Site, Córdoba
Research Site, Madrid
Research Site, Reus
Research Site, Nantes
Research Site, Cincinnati
Research Site, Zaragoza
Research Site, Cologne
Research Site, Bron
Research Site, Paris
Research Site, Scottsdale
Research Site, Vancouver
Research Site, London
Research Site, Chicoutimi
Research Site, Montreal
Research Site, Montreal
Research Site, New Territories
Research Site, Amersfoort
Research Site, Amsterdam
Research Site, Amsterdam
Research Site, Gouda
Research Site, Groningen
Research Site, Hoorn
Research Site, Tilburg
Research Site, Utrecht
Research Site, Oslo
Research Site, Stockholm
Research Site, Stockholm
Research Site, Coventry
Research Site, London
Research Site, London
Research Site, Manchester
Lead Sponsor
Amgen
INDUSTRY